Investing News Novartis Reports Positive Phase III Results for Lutathera in GEP-NETs September 25, 2023
Investing News Novartis Stock Surged as Company Announces a $15 Billion Stock Repurchase Program July 18, 2023
Investing News NVS Stock Rises as Nilotinib, a Leukemia Medication Is Licensed by Novartis to the Un-Backed Medicines Patent Pool October 20, 2022
Search
Novartis
